Synthesis and Characterization of Giant Plasma Membrane Vesicles and its Effect on Human Mesenchymal Stem Cells by Gaur, Deepanjali
  
 
 
Synthesis and Characterization of Giant 
Plasma Membrane Vesicles and its Effect 
on Human Mesenchymal Stem Cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Deepanjali Gaur 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                  Dept. of Biotechnology and Medical Engineering 
                  National Institute of Technology Rourkela 
 Synthesis and Characterization of Giant 
Plasma Membrane Vesicles and its Effect 
on Human Mesenchymal Stem Cells 
 
 
Dissertation submitted in partial fulfilment 
of the requirements of the degree of 
Master of Technology 
in 
Biomedical Engineering 
 
by 
Deepanjali Gaur 
(Roll Number: 215BM1001) 
 
based on research carried out 
under the supervision of 
Prof. Indranil Banerjee 
 
 
May, 2017 
Department of Biotechnology and Medical Engineering 
National Institute of Technology Rourkela
Dept. of Biotechnology and Medical Engineering 
National Institute of Technology Rourkela 
 
 
 
 
May 30, 2017 
 
 
Certificate of Examination 
 
 
Roll Number: 215BM1001 
Name: Deepanjali Gaur 
Title of Dissertation: Synthesis and Characterization 
of Giant Plasma Membrane Vesicles and its Effect 
on Human Mesenchymal Stem Cells 
 
 
 
We the below signed, after checking the dissertation mentioned above and the official 
record book (s) of the student, hereby state our approval of the dissertation submitted 
in partial fulfilment of the requirements of the degree of Masters of technology in 
Biomedical Engineering at National Institute of Technology Rourkela.  We are satisfied 
with the volume, quality, correctness, and originality of the work. 
 
 
 
 
      
 
Dr. Indranil Banerjee 
Supervisor 
  
Dept. of Biotechnology and Medical Engineering 
National Institute of Technology Rourkela 
 
 
 
Dr. Indranil Banerjee 
Assistant Professor 
 
May 30, 2017 
Supervisor’s Certificate 
This is to certify that the work presented in the dissertation entitled “Synthesis and 
Characterization of Giant Plasma Membrane Vesicles and its Effect on Human 
Mesenchymal Stem Cells” submitted by “Deepanjali Gaur”, Roll Number: 215BM1001, 
is a record of original work carried out by her under my guidance and supervision in the 
partial fulfilment of the requirements for the degree of Master of Technology in 
Biomedical Engineering at the Department of Biotechnology and Medical Engineering, 
National Institute of Technology Rourkela. Neither this dissertation nor any part of it has 
been submitted earlier for any degree or diploma to any institute or university in India or 
abroad. 
 
 
 
 
 
                                  Dr. Indranil Banerjee 
            Supervisor 
 
 
 
 
 
 
 
 
  
Dedication 
 
 
 
 
 
I dedicate this thesis to my 
parents and my loving sister 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 v 
 
Declaration of Originality 
 
 
 
I, Deepanjali Gaur, Roll Number 215BM1001 hereby declare that this dissertation entitled 
Synthesis and Characterization of Giant Plasma Membrane Vesicles and its Effect on 
Human Mesenchymal Stem Cells presents my original work carried out as a master’s 
student of NIT Rourkela and, to the best of my knowledge, contains no material previously 
published or written by another person, nor any material presented by me for the award 
of any degree or diploma of NIT Rourkela or any other institution. Any contribution made 
to this research by others, with whom I have worked at NIT Rourkela or elsewhere, is 
explicitly acknowledged in the dissertation. Works of other authors cited in this dissertation 
have been duly acknowledged under the sections “Reference” or “Bibliography”. I have 
also submitted my original research records to the scrutiny committee for evaluation of 
my dissertation. 
 
I am fully aware that in case of any non-compliance detected in future, the Senate of 
NIT Rourkela may withdraw the degree awarded to me on the basis of the present 
dissertation. 
 
 
May 30, 2017 
NIT Rourkela                                                                                Deepanjali Gaur 
 
 
  
 vi 
 
Acknowledgement 
Thinking and Feeling appreciation signifies that we believe in someone’s existence rather 
than the divine who rules everything. This thesis entitled “Synthesis and Characterization 
of Giant Plasma Membrane Vesicles and its Effect on Human Mesenchymal Stem 
Cells” is the successful outcome of guidance and support bestowed on me throughout my 
work. I would like to express my most sincere gratitude to every single being those devoted 
their time for successful completion of my thesis. 
 
I would like to show my foremost gratitude towards my Guide Dr. Indranil Banerjee who 
helped me with my thesis in every possible stage and encouraged me to do better.  I would 
also like to thank the Ph.D. scholars Senthilguru K., V. S. Sharan Rathnam and all my 
lab mates for their painstaking effort for the completion the thesis. 
 
Finally, I would not miss to thank heartily to my Parents, my sister and close friends 
Anurag Kushwanshi and Pratyush K. Patnaik for their unconditional love and 
encouragement shown towards me and completion of the thesis. Last but not the least, I 
would like to thank the Department of Biotechnology and Medical Engineering for 
providing such a stimulating atmosphere and nice work environment. 
 
                                                                                                     
May 30, 2017                                                                                               Deepanjali Gaur 
NIT, Rourkela                                  Roll Number: 215BM1001 
 vii 
 
Abstract 
Differentiation of mesenchymal stem cells to osteogenic lineage is a crucial step of in vivo 
bone remodelling and bone regeneration. In bone tissue engineering, numerous effort has 
been made for directed osteogenic differentiation of mesenchymal stem cells. A critical 
analysis of the literature revealed that in vivo, osteoblast itself induce the differentiation of 
mesenchymal stem cells towards osteogenic lineage. Keeping that perspective in mind here 
we hypothesized that giant plasma membrane vesicles (GPMV) derived from osteoblast 
can be as a ‘packaged cues’ for osteogenic differentiation of mesenchymal stem cells. 
Here we have reported the synthesis of giant plasma membrane vesicles (GPMVs) from the 
osteoblast MG-63 using a combination of paraformaldehyde (PFA) / dithiotheritol (DTT). 
To analyse the effect of different cellular constituents on the physico-chemical properties 
of the GPMV, osteoblast cells were treated with an actin blocker (cytochalacin-D) and a 
cholesterol sequester (methyl-β-cyclo dextrin) prior to GPMV generation. Size, shape and 
structural complexicty of the GPMV was characterized by image based analysis (phase 
contrast microscopy, fluorescence microscopy and electron microscopy) and by flow 
cytometry. The lipid extracted from the GPMVs was analysed by biochemical assay and 
NMR spectroscopy. Further, we fused the GPMV with the hMSCs and the fusion efficiency 
was analysed by confocal microscopy and flow cytometry. More than 15% of Fusion 
efficiency was observed. Proliferation of hMSC after fusion was analysed by MTT assay, 
PI based live/dead assay and confocal microscopy.  The osteogenic differentiation was 
investigated by checking the activity of alkaline phosphatase, extent of biomineralization 
and collagen synthesis. The RT-PCR based analysis of the expression of osteogenic 
markers revealed that hMSCs cultured in the presence of GPMVs shows increased 
expression of early and late osteogenic markers. 
 
Key words: Bone tissue engineering; GPMVs; hMSCs; liposome fusion; osteogenic 
differentiation. 
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Chapter 1 
Introduction 
Selective differentiation or site-specific differentiation of the human mesenchymal Stem 
Cells (hMSCs) towards osteogenic lineage is one of the pre-requisite of cell-based bone 
tissue engineering[1]. Many research groups have adopted different strategies to achieve 
the same. The methodology to achieve the same can be broadly categorised into:  
1. Chemical cues 
Dexamethasone, L-ascorbic acid, bone morphogenetic proteins (BMPs) and β-glycerol 
phosphate are well established and extensively studied chemical factors that induces 
osteogenic differentiation of hMSCs [2-4]. 
2. Physical cues 
Mechanical factors that affect the induces osteogenic differentiation of the hMSCs are 
shear stress and shear strain [5].  
3. Electrical cues  
Pulse-field and low frequency electromagnetic field directs the hMSCs to differentiate 
into osteogenic-lineage [6]. 
During the investigation it has been noted that in vivo, the differentiation of hMSCs got 
influenced by the presence of osteoblast, so far our understanding stated that it happens 
through the cell-cell communication as the hMSCs adjacent to the osteoblasts shows 
fibroblast-like morphology. The activation of the MAPKinase signalling pathway affects 
the transdifferentiation of the hMSCs to osteoblasts [7].  
This review of the literature suggests that the osteoblast delivers some chemical signals that 
are responsible for the osteogenic differentiation of hMSCs. This implies that if we are able 
to get a package comprised of such chemical cues from osteoblast. That may be separately 
used for osteogenic differentiation of the hMSCs. So far, this concept has been validated in 
cancer research where people have proved that micro vesicles synthesized by cancer cells 
contain a significant amount of chemical cues for modulating the response of neighbouring 
cells.  
In recent years, GPMVs has emerged as a promising system for studying cell membrane[8]. 
GPMVs are the membrane-bounded filled with fluid projections also known as blebs, 
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usually exclusive of the large cell organelles like golgi bodies, endoplasmic reticulum etc. 
which provide GPMVs a phase-lucent appearance [9]. These membrane blebs can be 
generated by both eukaryotic and prokaryotic living cells. The vesiculating agents plays an 
important role in the synthesis of the membrane blebs as the paraformaldehyde causes non-
specific cross-linking of the proteins and di-thiothritol causes cleaving of the disulphide 
and thioester bonds. The membrane actin known as cortical actin is present to provide 
structural stability to the system, naturally when the actin present cannot retain the cytosolic 
pressure to maintain the stability of the cell morphology it releases the membrane blebs to 
regain its cellular stability and structure [10].  
So far it has been observed that the GPMVs contain some information. Keeping this 
perspective in mind, here we have hypothesized that GPMV generated from osteoblast may 
have the capability to induce osteogenic differentiation of hMSCs. 
Under the stress-inducing conditions the blebbing of the membrane is observed and it’s an 
indication of cell-injury but the blebs formed are reversible blebs. These blebs have been 
explored and analysed thoroughly. On the other hand, the mechanism of generation and 
characterization of GPMVs is still not completely understood. Over the years, GPMVs have 
been proven an excellent acellular system to investigate the complexity and composition of 
the cell membrane. As the GPMVs are generated from live cells the native form of the cell 
membrane is conserved [11].  
 
 
Figure 1.1: Schematic representation of the in vivo bone remodeling by juxtacrine and paracrine 
signaling 
Mesenchymal 
stem cell 
Osteoblast  
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Chapter 2 
Literature Review 
 
2.1 Plasma Membrane Vesiculation 
Studying the composition and complexity of the cell membrane has always been an 
interesting topic among the researchers as it determines and gives better understanding of 
the in vivo signalling and other cell membrane mediated pathways. But the cell membrane 
system is tough to handle in the native structure. So, it leads to the development of new 
techniques to study the cell membrane system. Generation of membrane blebs is one such 
method of extracting the cell membrane in its native form and study it. Plasma membrane 
vesicles have proven to be an excellent model system. Chemical factors known as 
vesiculating agents have been extensively studied for the synthesis of membrane blebs. N-
ethymaleimide (NEM), paraformaldehyde(PFA) and di-thiothritol (DTT) [14] are currently 
used to induce the vesiculation of the cell membrane. Membrane vesicle can be used as the 
excellent delivery vehicle to drugs, growth factors and proteins. As derived from the the 
living system it maintains the natural composition and complexity of the cell membrane 
from which it has been synthesized. 
2.2 Giant Plasma Membrane Vesicles 
In 1919 Mary Jane Hogue reported the chemicals that can be used as the generate blebbing 
of the cell membrane. The hypertonic and hypotonic solution of various salts can be used 
to achieve the blebbing of the cells [15]. The older techniques to generate the were to 
homogenize the cells, perform isopycnic centrifugation etc. In 1976 Barry L Jacobs et.al 
reported a new method of generating the vesicles from the plasma membrane which can be 
further used to study the model system. The formaldehyde at a concentration of 25 mM to 
250 mM, 10 mM of N-ethymaleimide in the PBS buffer can generate the plasma membrane 
vesicles (PMVs), Di-thiothritol along with formaldehyde working solution can be used 
[16]. Giant plasma membrane vesicles (GPMVs) are the vesicles generated from the plasma 
membrane of the desired cell line. Various alkylating-cysteine chemical treatment induces 
the generation of the GPMVs. 
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2.3 Blockers Treatment 
Various blockers like colchicine and cytochalasin-b were used to block the generation of 
GPMVs [17], keeping the cells at 4ºC stops the generation of the plasma membrane 
vesicles. Here we have chosen two different blockers to study their effect on the synthesis 
and composition of the GPMVs. 
2.3.1 Cytochalasin-D 
The cytochalasin-D has been proven that it inhibits the polymerization of the actin 
monomers by inducing the secondary conformational changes in monomers in the presence 
of Mg+2. The actin plays an important role in the generation of the GPMVs as the blebbing 
of the membrane occurs when the cortical actin maintaining the cytoskeleton of cell can no 
longer retain the intracellular pressure. So, we want to investigate the effect of actin 
polymerization blocker on the kinetics of GPMVs generation and composition of lipids and 
proteins present in the generated GPMVs as compared to the control.  
2.3.2 Methy-β-Cyclodextrin 
One of the significant part of the eukaryotic cell membrane, it provides the fluidity to the 
cell membrane. Methy-β-cyclodextrin (MβCD) is the cholesterol sequester, depleting the 
cholesterol from the cell membrane by forming a MβCD-cholesterol dimer complex. 
MβCD can limit the growth kinetics of the cell by altering the composition of the plasma 
membrane [18].  
2.4 Bone Tissue Engineering 
Due to increased occurrences of bone disorders, the need for bone grafts is increasing 
corresponding to the demand. But, the availability of the autografts and allografts depends 
on the various factors which cannot be controlled. After several years of research still, the 
autograft serves as the gold standard as it does not face graft rejection from the host's body, 
the biggest disadvantages are double surgery and highly expensive. Allografts are highly 
histocompatible they can also be used after decellularization of bone matrix, bone chips 
etc.[19]. The various other strategies adopted to repair the bone disorders or fractures 
include bone cement and involvement of bone morphogenetic proteins. The bone graft 
designed in vitro should be osteoinductive as well as angiogenic in nature to support the 
regeneration of the bone on the site of implantation. This leads to the necessity to develop 
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the bone grafts in vitro for implantation into the patients.  
2.5 Human Mesenchymal Stem Cells 
Human mesenchymal stem cells (hMSCs) are the undifferentiated multipotent stem cells 
capable of differentiating mainly into different tissue types of mesenchymal lineages for 
example mesenchymal tissues such as bone, cartilage, muscle, ligament, tendon, adipose, 
and stroma and different cell types like fibroblast, osteoblast, adipocyte and chondrocytes. 
hMSCs are uniformly positive for these surface markers SH2, SH3, CD29, CD44, CD71, 
CD90, CD106, CD120a, CD124 and HLA-DR [20]. For osteogenic differentiation various 
chemical inducer are used like dexamethasone, β-glycerol phosphate, and ascorbate was 
prepared in the complete hMSCs expansion medium. For adipogenic differentiation was 
induced by treating the cells with 1-methyl-3-isobutylxanthine, dexamethasone, insulin, 
and indomethacin in complete expansion medium [21]. To induce the chondrogenic 
differentiation of the mesenchymal stem cells the isolated cells were cultured with 
transforming growth factor–b3 in incomplete expansion medium.  
 
 
Figure 2.1: Differentiation lineages of human Mesenchymal Stem Cells (21) 
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2.6 Strategies for inducing Osteogenic differentiation of 
hMSCs in vitro 
The in vivo bone remodelling and regeneration takes place due to the induction of the 
hMSCs into osteogenic lineage by the neighbouring osteoblast. So, researcher have 
achieved the same in vitro by co-culture of the osteoblast with the hMSCs. One of the major 
disadvantage of the co-culture is the different growth medium requirement by the different 
cell lines [21]. The induction of osteogenic differentiation by using the chemical factors is 
promising methodology. The mechanical factors like shear stress and shear strain has also 
proven to induce the osteogenic differentiation of the stem cell. Low frequency pulsed field 
electromagnetic induction also induces the same. 
2.7 Liposome Fusion Efficiency 
The fusion of the membrane is a naturally occurring process in the living organism to 
perform different tasks like repairing the damaged organelles, signalling pathway in the 
extracellular matrix, cell-cell communication and for the cells to adhere to the developing 
tissue or organ.  These behavioural characteristics can be further investigated and explored 
for various biomedical and biotechnical applications. Micro-injection, treatment with 
trypsin, polyethylene glycol [22] are few chemical inducers that promotes the fusion of the 
liposome with liposome or liposome to cell membrane. 
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Chapter 3  
Objectives and Work Plan 
3.1 Objectives 
1. Synthesis and characterization of giant plasma membrane vesicles from osteoblasts. 
2. Analysis of the fusion efficiency of giant plasma membrane vesicles with the human 
mesenchymal stem cells.  
3. Investigation of the osteogenic differentiation of human mesenchymal stem cells 
cultured in the presence of giant plasma membrane vesicles. 
 
3.2 Work Plan 
 
 
Figure 3.1: Schematic representation of the work plan for objective one 
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Figure 3.2: Schematic representation of the work plan for objective two and three 
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Chapter 4 
Material and Methods 
4.1 Materials  
The cell line MG-63 was obtained from NCCS, Pune. Human mesenchymal stem cells were 
obtained from HIMEDIA. India.Dulbecco’s Modified Eagle Media (DMEM), Fetal bovine 
serum (FBS), Dulbecco’s Phosphate buffer saline (DPBS), Antibiotic-antimycotic solution, 
trypsin-EDTA, paraformaldehyde, MTT assay kit, di-thiothreitol (DTT), glutaraldehyde, 
dimethylsulphoxide (DMSO), alizarin red, dexamethasone, L-ascorbic acid, β-glycerol 
phosphate was purchased from HIMEDIA. Ethanol was purchased from Merck. Propidium 
iodide (PI) was obtained from Sigma-Aldrich, Mumbai, India. Vybrant Dio, Cell Tracker 
Red and PI/RNase solution were obtained from Invitrogen, USA. Syringe water was 
purchased from Apollo pharmacy, NIT Rourkela, Orissa, India. Autoclaved distilled water 
was used throughout the experiments. 
4.2 Methodology 
4.2.1 Synthesis of Giant Plasma Membrane Vesicles  
For GPMV synthesis, osteoblasts (MG-63) were harvested by trypsinization and the cells 
were seeded at a density of 5.0* 105 cells per ml into T-25 culture flask. After two days of 
incubation, cells were washed once with GPMV buffer (10 mM HEPES, 150 mM NaCl, 
2mM CaCl2, pH 7.4), 1.5 ml of GPMV reagent was added (25 mM formaldehyde and 3 
mM DTT in GPMV buffer) and observed under the phase contrast microscope (Carl Zeiss 
Primovert). After 1 h of incubation at 37°C, the supernatant containing the GPMVs was 
taken and stored at 4°C until further use [10]. 
4.2.2 Labelling of Giant Plasma Membrane Vesicles      
For labelling the GPMV, the MG-63 cells were stained with the DiO working Solution (1µl 
vybrant DiO in 1 ml of Complete media) for 20 min. Wash once with GPMV buffer and 
then follow the aforementioned protocol to synthesise GPMV. After the overnight 
incubation, the GPMV suspension was centrifuged at 8000 rpm for 10 min. The 500μl of 
the GPMVs solution was discarded and a residual suspension containing GPMV was 
observed under Lieca SP8 confocal microscope [10]. 
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4.2.3 Synthesis of GPMV in presence of blockers 
For GPMV synthesis after the blocker treatment, two 70% confluent T-25 culture flask of 
MG-63 was taken, one was treated with cytochalasin-D an actin polymerization blocker it 
will inhibit the actin monomers to form the polymer and disrupts the cytoskeleton of the 
cells and the other one with methyl-β-cyclodextrin (MβCD) a cholesterol depleting agent 
it forms dimer complex with the cholesterol, once the cholesterol has been depleted the 
membrane fluidity will decrease providing rigidity to the cells. Cells were washed twice 
with PBS before blocker treatment. Blocking solution was added to culture flask. Working 
concentration of 10µM was used for cytochalasin-D and the time of exposure was 
optimized to be 30 min. and 500 µM was used for MβCD and the time of exposure was 
optimized to be 30 min. The MG-63 Cells were treated with the blockers and observed 
under Carl Zeiss Primovert Phase Contrast Microscope. 
4.2.4 Size analysis of Giant Plasma Membrane Vesicles 
4.2.4.1 Phase Contrast Microscopy 
After adding the GPMV buffer to the control and blocker treated flasks. The flasks were 
observed at different time period. At 400 X magnification to analyse the time dependent 
effect of GPMV buffer on cells and kinematics of the cells and investigate the effect of the 
blockers on the size and kinematics of the cells after the treatment with blockers i.e. 
cytochalasin-D and methyl-β-cyclodextrin. 
4.2.4.2 Environmental Scanning Electron Microscopy (ESEM) 
After collecting the supernatant from the T-25 culture flask incubated with GPMV buffer 
for the generation of GPMV from the osteoblast cell line i.e. MG-63. The GPMV 
suspension was stored at 4ºC overnight. After overnight incubation the GPMV suspension 
was centrifuged at 8000 rpm for 10 min. 500µl from the supernatant was removed and from 
the remaining GPMV suspension, 10μl of the supernatant was taken and drop was dried on 
glass slide overnight. The sample was observed under ESEM at 6000 X magnification. 
4.2.4.3 Fluorescence Microscopy 
Prior to the GPMV generation, the cells were stained with the DiO staining solution using 
the protocol mentioned in section 4.2.2. The cells were washed once with PBS and then 
working solution of the DiO was added and incubated for 20 min. The cells were treated 
prior to the generation of the GPMV the mg-63 cells were treated with cytochalsin-D and 
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methyl-β-cyclodextrin. Incubated for 30 minutes and then working solution of the was 
removed and washed twice with the PBS and GPMV buffer was added and observed under 
the fluorescence microscope for three different time-intervals i.e. 0-10 min., 20-25 min. and 
40-50 min. 
4.2.5 Analysis of membrane flipping of the GPMVs by Annexin V 
4.2.5.1 Samples 
Before generating the GPMVs the cells the cells were stained with DiO as aforementioned 
protocol. The blocker was done using the protocol mentioned in the section 4.2.3. The 2% 
annexin-V solution was prepared in the GPMV working solution so that the membrane 
flipping can be observed and phosphatidylserine flipping is present the blebs formed, and 
are the blebs different from the apoptotic blebs. The cells were incubated for 20 minutes in 
the working solution and then fixed using the 4% paraformaldehyde solution to observed 
the flipping in the membrane while the GPMV are in due process of generation and then 
observed under the lieca SP8 Confocal microscope and the image analysis was done using 
the leica lasX software. 
4.2.5.2 Positive Control 
For the positive control meaning to induce the apoptosis in the cells. The cells were treated 
with 125 µM solution of hydrogen peroxide which is an apoptotic inducer. Cells were 
incubated with hydrogen peroxide for 2 hr. and then washed once with the PBS and then 
2% annexin-V solution was added. The cells were incubated for 20 minutes in the working 
solution of hydrogen peroxide and then fixed using the 4% paraformaldehyde solution The 
cells were observed under the Lieca SP8 confocal microscope and the image analysis was 
done using the Leica lasX software. 
4.2.6 Analysis of membrane integrity by Propidium Iodide 
After the GPMV was generated as aforementioned protocol the GPMV was stored at 4ºC 
overnight. After overnight incubation, the GPMV were centrifuged at 8000 rpm for 10 min. 
Upper half volume of the buffer was removed and propidium iodide working solution was 
added to the GPMVs and incubated for 20 min. to analyse the membrane integrity of the 
cells as the propidium iodide will bind to the DNA but it can only penetrate inside the cells 
if the membrane is disintegrated.  The flow cytometric analysis of the samples was done 
using the C6 BD accuri flow cytometer and data was analysed using C6 BD accuri software. 
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4.2.7 Analysis of membrane Complexity by Flow Cytometry 
The cells were stained with DiO using the protocol mentioned in section 4.2.2. prior to the 
GPMV generation as aforementioned protocol. The cells were treated with the blockers 
before generating the GPMVs. The GPMVs using the PFA/DTT working solution for all 
the three samples i.e. for the control and blocker treated cells and analysed using the C6 
BD accuri flow cytometer and data was analysed using C6 BD accuri software for side 
scatter and forward scatter as the side scatter will define the complexity of the membrane 
and forward scatter will give the information about the size of the sample.  
4.2.8 Lipid extraction from GPMV 
The lipid analysis of the lipid extracted from the GPMV generated from the untreated and 
treated MG-63. To analyse the composition of the lipid the lipid was extracted using the 
protocol given by Dyer and Bligh after doing the necessary modification in the protocol 
followed. The GPMVs were generated using the protocol mentioned in the section 4.2.1.the 
GPMV suspension was kept for overnight incubation at 4ºC. lipid extraction was performed 
using the methanol: chloroform ratio of 2: 1. 2 ml of chloroform: methanol solution was 
added to 2 ml of GPMV suspension. The suspension was mixed rigorously and left 
untouched for 30 min. for the phase separation of the two layers. The bottom layer was 
collected in the separate tube. The lipid extraction process was repeated twice using the 
chloroform and GPMV suspension in the ration of 1: 1. The bottom layer was collected in 
the same tube. After the lipid extraction the solution was washed once with the 1 M KCl 
solution for the removal of the salts. The KCl solution and lipid solution was added in the 
ratio of 0.4:1 the solution was shaken rigorously and left untouched for 30 min. after the 
incubation the upper layer was removed. To remove the chloroform and obtain the lipid the 
samples were dried using a rotating evaporator. The extracted lipid was stored at room 
temperature until further downstream analysis.  
4.2.9 Characterization of the Lipids Extracted from the Giant Plasma 
Membrane Vesicles 
4.2.9.1 Biochemical Assay 
4.2.9.1.1 Cholesterol Estimation Assay 
The quantification of the cholesterol was done using the protocol given by Bowman and 
Wolf by modifying the protocol to perform the assay. The solution of ferric chloride was 
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prepared by taking 0.8 ml of 2.5% solution of ferric chloride. The ferric chloride was 
prepared in the glacial acetic acid. The water was added to prepare 85% of H3PO4 was 
prepared using the 9.2 ml of concentrated sulphuric acid. The lipid was extracted from the 
generated GPMV using the chloroform methanol extraction process. The samples were 
dried in the inert nitrogen system. The dries samples were diluted using the 500µl of the 
ethanol and 500 µl of the ferric chloride solution. The solution was incubated for 30 
minutes, pinkish colour shows the presence of the cholesterol. and then the absorbance was 
taken at 550 nm.  
4.2.9.1.2 Phosphorus Estimation Assay 
To evaluate the amount of total phosphorus present in the lipid extracted by using 
chloroform methanol extraction process, as the total phosphorus will directly corresponds 
to the total phospholipid present in the system. Potassium dihydrogen phosphate was taken 
as the standard for the quantification. The standard samples were prepared in water from 
0.01µM to 0.04 µM concentration was used. The dried lipid samples were taken and 90µl 
of 8.9 N Sulphuric acid was added. After the addition of sulphuric acid tubes were heated 
at the temperature of 210ºC for 25 min. after the heating leave the test tubes to cool down. 
After the tubes have cooled down add 30µl of hydrogen peroxide and heat for 30 min. at 
210 ºC. let the test tubes cool down and add 780µl of water. Add 100µl of ammonium 
molybdate tetrahydrate solution and solution was mixed thoroughly using vortex and 10µl 
of ascorbic acid was added. The test tubes were heated at 100º for 7 min. absorbance was 
taken at 820 nm using UV-Visible spectrophotometer. The standard curve was plotted to 
determine the concentration of phosphorus present in the samples.  
4.2.9.2 Nuclear Magnetic Resonance (NMR) spectroscopy 
The lipids were extracted by aforementioned protocol using chloroform methanol 
extraction process and dissolved in the 2.5ml of CDCL3: CD3O.D. (2:1) and 500µl of 
sample in the NMR tube using the syringe and analyse for proton and phosphorus 
spectroscopy and analysis by GSim NMR spectroscopy software [23]. 
4.2.10 Labelling of hMSCs with Cell Tracker (Red)  
T-25 culture flask of hMSCs was taken at 60-80% confluency, spent media was removed. 
The cells were harvested by trypsinization. 1 ml of cell tracker (1X) was added to the cell 
suspension and incubated for 45 min. at 37°C. After the incubation, the cell suspension was 
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centrifuged. The supernatant was removed and the cells were washed twice with media. 
The cell pellet was obtained by centrifugation and re-suspended in 1ml of media until 
further use. 
4.2.11 Fusion of DiO labelled GPMV generated from MG-63 to cell 
tracker labelled hMSCs 
500μL of the cell suspension was taken and 500μL of the GPMV was taken after overnight 
incubation at 4ºC and then the suspension was centrifuged 12000 rpm for 10 minutes and 
the upper supernatant was removed and then lower supernatant was taken in the 
microcentrifuge tube along with the cell suspension and was centrifuged at 2000 rpm for 2 
min. The ratio of cell: GPMV was kept 10:1 to increase the fusion efficiency of the GPMVs 
with the cells. The cells were seeded accordingly for further downstream analysis. 
 
Figure 4.1: Schematic representation of the fusion of GPMV with the human mesenchymal stem 
cells.  
4.2.12 Analysis of the Fusion efficiency of hMSCs with GPMV  
4.2.12.1 Confocal microscopy 
The hMSCs were centrifuged with the GPMV and after that seeded in the prepared confocal 
wells sticking the wells with PDMS on the glass cover slips and incubated for 2 h and then 
after fixed with 4% paraformaldehyde solution and then observed under leica TCS SP8 
confocal microscope and was analysed using leica LAS-X software. 
4.2.12.2 Flow Cytometry 
The hMSCs were centrifuged with the GPMVs (stained with the DiO) to induce the fusion 
and the flow cytometric analysis was done to analyse and verify the fusion efficiency of the 
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cells with the GPMV using the BD C6 flow cytometer and the analysis was done using the 
FCS express software. 
4.2.13 Cell proliferation study of the hMSCs Cultured in presence of 
GPMV 
4.2.13.1 Phase Contrast Microscopy 
The hMSCs were centrifuged with the GPMV and after that seeded in the 12-well culture 
plate and incubated for 24 h and 96 h and observed under carl zeiss phase contrast 
microscope at 100X magnification. 
4.2.13.2 Confocal Microscopy 
The hMSCs were centrifuged with the GPMV (stained with Dio dye using the protocol 
mentioned in the section 4.2.2.) and after that seeded in the confocal wells and incubated 
for 12 h were observed under leica TCS SP8 confocal microscope and was analysed using 
leica LAS-X software. 
4.2.13.3 MTT assay 
hMSCs with GPMV were seeded at the density of 5* 103 cells/well in 96-well culture plate 
and incubated for 24 h and 96 h. Cell proliferation was assessed by MTT assay to 
investigate the effect of GPMV and GPMV buffer on the morphology and growth of the 
hMSCs. The absorbance was measured at 595nm. 
4.2.13.4 Propidium Iodide(PI)-Based live/dead assay 
The hMSCs with GPMV were seeded at a population of 1* 105 cells/well in 6-well culture 
plate and incubated for 24 h and 96 h. The Cells were harvested using the trypsin-EDTA 
and the cell suspension was centrifuged and the supernatant was removed. The cells were 
re-suspended in the media containing the propidium iodide working solution to the stain 
with the PI and incubated for 20 min. at room temperature in dark. Vortex each sample 
before analysing it to make single cell suspension. The samples were analysed using C6 
BD accuri flow cytometer and data was analysed using C6 BD accuri software. 
4.2.14 Preparation of differentiation media 
The differentiation media was prepared using 100nM of dexamethasone, 10nM of L-
ascorbic acid and 30nM of β-glycerphosphate in the low glucose expansion media 
containing 10 % FBS and 1% antibiotic-antimycotic solution. 
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4.2.15 Osteogenic differentiation study of the hMSCs cultured in 
presence of GPMV 
The cells were seeded at the density of 5* 104 cells/well in 12-well culture plate after the 
fusion was performed using the aforementioned protocol. Following assays was performed 
as mentioned in the protocols below: 
4.2.14.1 Phase Contrast microscopy 
The hMSCs were centrifuged with the GPMV and after that seeded in the 12-well culture 
plate and incubated for 14 days and observed under carl zeiss phase contrast microscope at 
100X magnification. 
4.2.14.2 Alkaline phosphatase Assay 
After 14 days of incubation, the cells were trypsinized using trypsin-EDTA, the cell was 
lysed using 0.1% of triton-X. 50μl of cell lysate was taken and 50μl of alkaline phosphatase 
buffer was taken, the plate was incubated overnight and taken the O.D. at 405 nm. 
4.2.14.3 Alizarin Red staining 
After 14 days of incubation, cells were washed once with PBS, 1 ml of dye was added for 
1 h. The plate was kept on an orbital shaker. The supernatant was removed and washing 
was done thrice to remove the dye with water, the plate was kept on an orbital shaker. 
Observed under the carl zeiss primovert phase contrast microscope. 10% cetyl pyrimidine 
chloride was added and incubated for 30 minutes. Absorbance was taken at 550 nm. 
 
4.2.14.4 Collagen estimation Assay  
After 14 days of incubation, cells were washed once with PBS. The cells were fixed using 
the bouin’s fluid for 1 h under continuous shaking. Fixing solution was removed and the 
sample was air dried. Sirius dye solution was added and the plate was incubated for 1 h 
under continuous shaking. The dye was removed and cells were washed once with HCl 
(0.01N) solution and observed under carl zeiss primovert phase contrast microscope. After 
microscopic analysis, NaOH (0.1N) solution was added and was kept on a shaker for 30 
min. Absorbance was measured at 550 nm. 
4.2.14.5 Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)  
The mRNA was isolated and synthesized using the one-step Qiagen RNeasy Kit and then 
then cDNA was synthesized using the Bio BhartiMuLV Reverse Transcriptase Kit and the 
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steps were followed as written in the user manual. The genes were amplified using the 
primers mentioned in the table below and running the PCR for 25 cycles. The samples were 
analysed by running the samples on the 8% agarose gel containing 1% of ethidium bromide 
solution. The band intensity analysis was done by using the NIH Image J software. 
Glyceraldehyde 3 phosphate dehydrogenase was taken as control for the analysis.  
 
Table 4.1: List of Primers used for osteogenic differentiation study of the hMSCs fused and 
cultured in the presence of GPMV 
Gene Primer Type Primer sequence (5'-3') 
Glyceraldehyde 3 phosphate 
dehydrogenase (GAPDH) 
Forward CATGAGAAGTATGACAACAGCCT 
Reverse AGTCCTTCCACGATACCAAAGT 
Runt-related transcription 
factor 2 (RunX2) 
Forward TTTACRRACACCCCGCCAGTC 
Reverse CAGCGTCAACACCATCATTCTG 
Alkaline 
Phosphatase(ALP) 
Forward GACAAGAAGCCCTTCACTGCC 
Reverse CAGACTGCGCCTGGTAGTTGT 
Collagen type I (Col1) 
Forward AGACTGGCAACCTCAAGAAGGC 
Reverse CGGGAGGTCTTGGTGGTTTTGT 
Osteocalcin (OC) 
Forward GTGCAGAGTCCAGCAAAGGTG 
Reverse TCAGCCAACTCGTCACAGTCC 
 
4.1.16 Osteogenic differentiation study of the hMSCs cultured in 
presence of GPMV buffer  
The cells were seeded at the cell density of 5* 103 cells per well in 12-well culture plate 
with three different concentrations of the GPMV buffer i.e. 50µl, 100µl and 200µl. 
Following assay was performed as mentioned: 
Alkaline phosphatase Assay 
After 14 days of incubation, the cells were trypsinized using trypsin-EDTA, the cell was 
lysed using 0.1% of Triton-X. 50μl of cell lysate was taken and 50μl of alkaline phosphatase 
buffer was taken, the plate was incubated overnight and taken the O.D. at 405 nm. 
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4.1.17 VEGF expression study of the hMSCs cultured in presence of 
GPMV  
100µl of the sample was taken from the growth medium of the cells and added to the pre-
coated wells and incubate for 2h. on orbital shaker. After the incubation the wells were 
washed for 6 times with the wash buffer The 100µl of biotin-conjugated primary antibody 
was added and incubate for 1 h. on orbital shaker. The wells were washed properly with 
the wash buffer. 100µl streptavidin-HRP was added to the plates and incubated for 30 min. 
in dark. After 30 min. of incubation add 100µl of STOP solution and the absorbance was 
observed at 620 nm using ELISA microplate reader.  
4.1.18 Statistical analysis  
All the data were analysed for statistical significant difference between the samples using 
the ANOVA-single factor method of analysis, where α=0.5 and p-value < 0.05. 
 
 
 
 19 
 
Chapter 5 
Results and Discussion 
5.1 Synthesis of Giant Plasma Membrane Vesicles 
 
 
 
Figure 5.1: Synthesis of GPMVs stained with vybrant DiO and observed under confocal 
microscope 
The labelling of the MG-63 cells with vybrant Dio was properly done, as we can observe 
in figure 5.1 that the synthesis and labelling of the GPMV is a simultaneous process. 
5.2 Size analysis of Giant Plasma Membrane Vesicles 
5.2.1 Phase Contrast Microscopy 
 
 
Figure 5.2:  Phase Contrast Microscopy of the generating GPMVs 
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Table 5.1: Size analysis by Image J software 
 
Sample Average 
diameter 
(μm) 
Range (μm) 
G1 10.9 20-6 
G2 8.4 15-4 
G3 9.8 16-7 
 
The cells were treated with the blockers for the optimized time period which was 30 min. 
After the blocker treatment the GPMV working solution was added and the flasks along 
with the GPMV buffer was incubated for 45 min. For GPMV to come in suspension it was 
kept on an orbital shaker. Time dependent microscopy was done to analyse the size and 
effect of blocker on GPMV synthesis. It was clearly observed that the blockers resist the 
blebbing of the membrane. The average size of the GPMV after the cells were treated with 
the cytochalasin-D and methyl-β-cyclodextrin was significantly smaller as compared to the 
GPMV generated from the untreated MG-63 cells. The size of the GPMV was calculate 
using the NIH Image J software. 
5.2.2 Environmental Scanning Electron Microscopy(ESEM) 
 
 
Figure 5.3: Analysis of generated GPMVs under Environmental scanning electron microscope 
Table 5.2: Size analysis of the GPMVs using NIH Image J software 
Sample Average 
diameter 
(μm) 
Range (μm) 
G1 7.8 12-4 
G2 3.2 6-2 
G3 3.9 5-2 
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The size of the GPMV calculated by analysing it using the Image J software by NIH. The 
size of GPMV was observed to be reduced this is because of the overnight drying of the 
sample before observing the sample by scanning electron microscopy. 
5.2.3 Fluorescence Microscopy 
 
 
Figure 5.4: Time dependent fluorescence microscopy of the GPMVs stained with DiO 
 
The size and kinematics of the synthesis of GPMV was significantly affected by the treating 
the cells with the blockers prior to the generation of the GPMV. As cytochalasin-D affects 
the cytoskeleton made by myosin-actin filaments the induction of membrane blebbing was 
inhibited by the treatment thus, affecting the size of the vesicles. The cholesterol sequester 
treatment i.e. treatment with methyl-β-cyclodextrin the membrane fluidity is decreased 
thereby reducing the membrane fluidity and inhibiting the synthesis of GPMV. Different 
kind of membrane Blebbing kinetics was observed by performing the time-dependent 
microscopy of the GPMV stained with DiO and observed under fluorescence microscope. 
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Figure 5.5: Kinetics of GPMV generation 
Size analysis was done using the NIH Image J software and the graph was plotted in the 
origin to analyse the kinetics of GPMV generation. It was observed that the cells treated 
with the cytochalsin-D resist the membrane blebbing and GPMV synthesized are of 
smallest size. 
5.3 Analysis of membrane flipping of the GPMVs by 
Annexin V 
 
Figure 5.6: Analysis of membrane flipping by staining the GPMVs with DiO and Annexin-V by 
confocal microscopy 
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The pro-apoptotic cells exhibit a unique property of membrane flipping the phospholipid 
phosphatidylserine from the cytosolic side of the cell membrane flips to the outer side of 
the membrane. The annexin-V binds with the phosphatidylserine and phycoerythrin 
fluorescent dye is attached with the annexin-V and gives red colour. Here, we have induced 
apoptosis in the MG-63 cells by using the hydrogen peroxide as apoptosis inducer. 
The GPMV was produce for all the three samples. No significant membrane flipping was 
observed in blebs formed in the presence of GPMV working solution. Whereas, in the case 
of positive control membrane flipping was observed in the apoptotic blebs. 
5.4 Analysis of membrane integrity by Propidium Iodide 
 
 
Figure 5.7: Analysis of the integrity of the membrane by flow cytometry of the generated 
GPMVs by using Propidium Iodide 
The membrane integrity of the GPMV was analysed using the propidium iodide dye as it 
will only penetrate the cell when the membrane is disintegrated and the dye will bind with 
the DNA. Here in all the three cases as observed in the figure 5.7 was less than 3% of 
population has been observed to take up the stain which is not significant. That proves that 
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the membrane is not leaky it’s a complete intact vesicle and the integrity of the membrane 
was maintained in the synthesis of GPMV. 
5.5 Analysis of membrane Complexity by Flow Cytometry 
 
 
Figure 5.8: Analysis of the membrane complexity by flow cytometry of the generated GPMVs by 
flow cytometry 
Table 5.3: Size analysis of the GPMVs using Image J software 
 
The complexity of the membrane was analysed using the forward scatter plot of flow 
cytometry as shown in figure 5.8. The GPMVs generated after the blocker treatment shows 
a distinct and clear difference in the composition of the plasma membrane vesicles. The 
number of GPMVs generated was very less in the cells treated with the blockers. As the 
blocker treatment inhibits the blebbing of the membrane. The resistance offered by the 
blocker treatment was clearly observed by the flow cytometry analysis. 
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5.6 Characterization of the Lipids Extracted from the 
Giant Plasma Membrane Vesicles 
5.6.1 Biochemical Assay 
5.6.1.1 Cholesterol Estimation Assay 
 
 
Figure 5.9: Standard curve for the analysis of the cholesterol present in the lipid extracted from 
the GPMV by UV-Visible spectroscopy 
Table 5.4: Concentration of Cholesterol estimated by using the equation derived from standard 
curve 
Samples  Concentration (mg/ml) 
G1 1.107 
G2 1.648 
G3 0.641 
 
As the literature suggests that the methyl-β-cyclodextrin is cholesterol sequester, it removes 
the cholesterol present in the membrane by forming a dimer complex with the cholesterol 
thus, affecting its fluidity. The biochemical assay was used to estimate the amount of 
cholesterol present in the lipid extracted by using the chloroform: methanol extraction 
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process. Table 5.4 shows the concentration of the cholesterol present using the equation 
derive from the standard curve. It was observed that the lipid extracted from the GPMV 
generated after the cells were treated with methyl-β-cyclodextrin was significantly lower 
than the other two samples. This proves that the methyl-β-cyclodextrin works as the 
cholesterol sequester. 
5.6.1.2 Phosphorus estimation Assay 
 
 
Figure 5.10:  Standard curve for the analysis of the phosphorus present in the lipid extracted from 
the GPMV by UV-Visible spectroscopy 
Table 5.5: Concentration of phosphorus lipid was calculated using the equation derived from 
standard curve  
Samples  Concentration(µmolar) 
G1 0.0157 
G2 0.0182 
G3 0.0361 
 
The phosphorus in the total phospholipid was calculated using the equation derived after 
plotting the standard curve for the phosphorus estimation. The lipid extraction was done 
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using the chloroform methanol lipid extraction method. The phosphorus concentration was 
significantly higher in sample G3 of the lipid extracted from the GPMV synthesized after 
the cells were treated methyl-β-cyclodextrin as compared to sample G1 and G2 as shown 
in table 5.5. 
5.6.2 Nuclear Magnetic Resonance spectroscopy 
 
Figure 5.11: NMR spectroscopy of the lipid samples extracted from the generated GPMV 
 
The nuclear magnetic resonance spectroscopy was performed to analyse the phospholipids 
quantitatively and qualitatively present in the lipid extracted from the GPMVs using the 
chloroform methanol extraction method. The peaks were assigned in the figure 5.11 using 
the reference shown in figure 5.12 as shown below which was described by [24]. We were 
able to assign nearly all the peaks this proves that the lipid composition of GPMV is same 
lipid composition of the cell membrane. The areas under the peak was used to analyse the 
data quantitatively. The peaks clearly show a difference in the phospholipid composition 
in the samples G1, G2 and G3. This validates that the blocker treatment affects the 
complexity as well as composition of the GPMV. The analysis of the peaks was done using 
the NMR spectroscopy software. 
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Figure 5.12: Reference for NMR spectroscopy of the lipid samples extracted from the 
generated GPMV [24] 
5.7 Analysis of the Fusion efficiency of hMSCs with GPMV  
5.7.1 Confocal microscopy 
 
 
Figure 5.13: Fusion analysis of the hMSCs stained with cell tracker red and GPMV Stained with 
the DiO vybrant dye 
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As previously described in the schematic that the GPMVs were stained with the DiO and 
hMSCs were stained with the cell tracker red. If the fusion is induced, then the fused hMSCs 
will give a orangish-yellowish shade of colour. As after the fusion the GPMVs stain that is 
vybrant Dio will leach out and spread in the cell membrane. Figure 5.13 clearly shows that 
the GPMVs in all the three samples G1, G2 and G3 have undergone the fusion with the 
hMSCs. This proves our hypothesis that the GPMVs can fuse with the live cells. Further as 
shown in the Figure 5.14 the flow cytometric analysis was done to evaluate the fusion 
efficiency. It was observed that more than 15% of the cells were fused with the GPMVs as 
they take up the GPMVs stained with the DiO and shows fluorescence. From figure 5.14 
and Figure 5.15 it is established that the GPMVs fusion with the hMSCs can be achieved 
by centrifugation based method. 
5.7.2 Flow Cytometry 
 
 
Figure 5.14: Fusion analysis of the hMSCs stained with cell tracker red and GPMV Stained with 
the DiO vybrant dye by flow cytometry 
5.8 Cell proliferation study of the hMSCs Cultured in 
presence of GPMV 
 
To evaluate that whether the presence of GPMVs or GPMV buffer in very less quantity is 
having any toxic effects on the cell growth and proliferation the Following studies was 
performed on the hMSCs after the cells were fused with the GPMV and then cultured in 
the presence of GPMVs. The phase contrast microscopy images in figure 5.15 shows that 
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the hMSCs have attain their natural morphological shape after the incubation for 24 h and 
96 h. Proving that after the fusion the cells will proliferate naturally. Fusion did not affect 
the morphology of the cells. 
5.8.1 Phase Contrast Microscopy 
 
 
Figure 5.15: Phase contrast microscopy of the hMSCs fused with the GPMV  
5.8.2 Confocal Microscopy 
 
 
Figure 5.16: Confocal microscopy of the hMSCs fused with the GPMV stained with DiO 
Fusion was performed by a centrifugation based method, the GPMVs were stained with 
vybrant DiO. After the fusion, the cells with GPMVs were seeded in the prepared confocal 
wells. After 12 h of incubation at 37ºC at 5% CO2 the cells were observed under the lieca 
SP8 confocal microscope and images were analysed using lieca LasX software. 
hMSCs + G1 hMSCs + G2 hMSCs + G3
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5.8.3 MTT assay 
 
 
Figure 5.17: Cell proliferation study using MTT assay of the hMSCs fused with the GPMV 
stained with DiO 
The cell proliferation index calculated from the MTT assay shows the cell viability of more 
than 75% in all the three samples G1, G2 and G3. The cells after the fusion is performed 
are proliferating without any cytotoxic effect of GPMVs or GPMV buffer on the cells as 
shown in figure 5.17. 
5.8.4 Propidium iodide based live/dead assay 
 
 
 
         
Figure 5.18: Propidium Iodide based livedead assay, analysed using flow cytometry 
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Flow cytometric analysis was done after staining the cells with the propidium iodide (PI) 
stain. PI will bind with DNA only after it enters into the cells after the membrane 
disintegration. This differentiate between the live and dead cell population present in the 
sample. The live/dead assay was performed for day 1 and day 4. No distinct dead cell 
population of hMSCs was observed after the fusion of hMSCs with the G1, G2 and G3.  
5.9 Osteogenic differentiation study of the hMSCs cultured 
in presence of GPMV 
5.9.1 Phase contrast microscopy 
 
 
 
 
Figure 5.19: Phase contrast microscopy of the hMSCs cultured in the presence of the GPMV and 
the growth medium used was A) Expansion medium and B) Differentiation media 
Phase contrast microscopy was performed to observe the morphological changes in the 
MSCs when cultured in expansion median and differentiation media. Significant difference 
in the morphology of the cells was observed as we can see in the figure 5.19. this proves 
that the differentiation media induce some morphological changes when the it induces the 
osteogenic differentiation of the hMSCs. 
B. 
A. 
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5.9.2 Alkaline phosphatase assay 
 
 
Figure 5.20: Analysis of alkaline phosphatase activity of the hMSCs cultured in the presence of 
the GPMV in expansion and differentiation media 
 
The alkaline phosphatase is the enzyme that is directly proportional to the bone metabolism 
that means the cells produce this when the osteoclast differentiates into osteocyte. The ALP 
quantitative analysis shows that the when the hMSCs fused with GPMV s and cultured in 
the presence of GPMVs they differentiate into osteogenic lineage. hMSCs with G2 shows 
the highest amount of ALP activity as compared to hMSCs + G1 and hMSCs + G3, but all 
three of them was significantly higher than the level of expression in the hMSCs. 
5.9.3 Alizarin red staining 
 
The Alizarin red staining (ARS) was performed to analyse the matrix deposition or 
mineralization of the cells. As compared to hMSCs all the three samples hMSCs + G1, 
hMSCs + G2 and hMSCs + G3 shows higher level of matrix deposition on the cells. In 
differentiation media this value was relatively higher as observed by the phase contrast 
microscopy and then confirmed by dissolving the matrix deposited by using cetyl 
pyrimidine chloride solution and taking the absorbance at 550 nm.  
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Figure 5.21: Phase Contrast microscopy of matrix deposition on the hMSCs cultured in the 
presence of the GPMV in A) Expansion media and B) Differentiation media 
 
 
Figure 5.22: Analysis of matrix deposition on the hMSCs cultured in the presence of the GPMV 
in expansion and differentiation media 
 
By quantitative assay also it was proved that the mineralization of the bone matrix was 
higher in the samples, though no significant difference was observed in between the 
samples. 
A
..
a 
B
..
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5.9.4 Collagen estimation Assay 
 
 
 
Figure 5.23: Phase contrast microscopy of the collagen synthesis by the hMSCs cultured in the 
presence of the GPMV in A) Expansion media and B) Differentiation media 
 
 
Figure 5.24: Analysis of the total collagen synthesis by the hMSCs cultured in the presence of the 
GPMV in expansion and differentiation media 
Collagen is required to provide bone strength. The synthesis of collagen helps in bone 
remodelling and repair. The study of collagen synthesis was done by using the phase contast 
A. 
B. 
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microscopy then dissolving the sirius dye stain in the sodium hydroxide solution for 
quantitative analysis and the absorbance was measured at 550 nm. figure 5.23 and figure 
5.24 both indicates the higher synthesis of total collagen by the hMSCs fused with the 
GPMVs and then cultured in the presence of GPMVs as compared to hMSCs. Collagen is 
an early osteogenic marker its increase expression proves that the GPMVs induces 
osteogenic-differentiation of the hMSCs. 
5.9.5 Reverse Transcriptase – Polymerase Chain Reaction 
 
 
Figure 5.25: Bands of the cDNA observed after performing the RT-PCR analysis of the mRNA 
isolated from the cells cultured in the expansion media 
     
Figure 5.26.1: Intensity analysis of the cDNA observed after performing the RT-PCR analysis 
using NIH Image J software. A) Relative ALP expression B) Relative Runx2 expression 
A
. 
B. 
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Figure 5.26.2: Intensity analysis of the cDNA observed after performing the RT-PCR analysis 
using NIH Image J software C) Relative Col 1 expression D) Relative OC expression 
For the RT-PCR analysis we selected four different osteogenic markers: alkaline 
phosphatase, collagen 1, Runt related transcription factor and octeocalcin.  All the early 
and late osteogenic markers show that the hMSCs fused and cultured in the presence of 
GPMVs have a significantly higher amount of markers expression as compared to MSCs. 
As shown it the figure 5.26.1 and 5.26.2 Thus, it’s been concluded that GPMVs directs 
hMSCs to osteogenic lineage. 
 
 Figure 5.27: Bands of the cDNA observed after performing the RT-PCR of the isolated mRNA 
cultured in the presence of differentiation media 
C. D
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Figure 5.28: Intensity analysis of the cDNA observed after performing the RT-PCR of the 
hMSCs cultured in the differention media and the analysis was done using Image J software a) 
Relative ALP expression B) Relative Col 1 expression C) Relative Runx2 expession D) Relative 
OC expression 
 
For the RT-PCR analysis we selected four different osteogenic markers: alkaline 
phosphatase, collagen 1, runt related transcription factor and octeocalcin. After 14 days the 
mRNA was isolated and one step RT-PCR was performed. The results were analysis by 
running the 8% agarose gel with 1% ethidium bromide.  All the early and late osteogenic 
markers show that the hMSCs fused and cultured in the presence of GPMVs have a 
significantly higher amount of markers expression as compared to hMSCs. As shown it the 
Figure 5.28. Thus, it’s been concluded that GPMVs directs hMSCs to osteogenic lineage 
even in the presence of differentiation media used as growth medium. 
 
A. B. 
C. D. 
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5.10 Osteogenic differentiation study of the hMSCs 
cultured in presence of GPMV buffer 
 
 
Figure 5.29: ALP activity analysis of the hMSCs cultured with  three different concentration of 
GPMV buffer 
When we seed the cells for the downstream analysis, a very little of GPMV buffer also 
enters into the system. So, to remove that possibility that the GPMV working soluton may 
induce the differentiation of the hMSCs to osteoblasts. Three different concentration of 
the GPMV buffer was used. The study concludes that the GPMV buffer does not induce 
the diffrentiation of hMSCs. 
 
5.11 VEGF expression in the hMSCs cultured in presence 
of GPMV 
For the bone to remodel or repair both osteogenesis and angiogenesis should happen 
simultaneously. The release of VEGF in the medium to induce the growth of proper 
vascular system in the tissue or graft. Here, we observe that the VEGF expression in the 
hMSCs fused and then cultured in the presence of GPMV was lower than the MSCs as 
shown in figure 5.30 this may be because the GPMV generated does not carried the 
signalling molecule required for the VEGF expression. 
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Figure 5.30: VEGF expression analysis of the the hMSCs cultured in the prescence of GPMV 
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Chapter 6 
Conclusion 
 
GPMV were synthesized from osteoblasts by using the working solution of 
paraformaldehyde/dithiothreitol. GPMV generated in the presence of blockers MβCD and 
Cyto-D notable difference was observed in the size and kinetics of GPMV generation. As 
cytochalasin-D inhibits the actin polymerization thus, inhibiting the membrane blebbing. 
MβCD is a cholesterol depleting agent is being proved by performing the biochemical assay 
and NMR spectroscopy. The fusion of GPMVs with hMSCs by using centrifugation based 
method is possible and is an efficient method to achieve the fusion. The analysis of fusion 
was done using confocal microscopy and flow cytometry. More than 15 % fusion efficiency 
was investigated by flow cytometry analysis. The quantitative osteogenic study showed 
that the alkaline phosphatase activity, total collagen synthesis and matrix deposition was 
significantly high in the hMSC fused with the GPMV i.e. hMSCs + G1, hMSCs + G2 and 
hMSCs + 3. This proves the hypothesis that the GPMVs can induce the osteogenic 
differentiation of the hMSCs. The RT-PCR study shows that the mRNA isolated for early 
and late osteogenic markers is significantly higher in the MSCs culture in the presence of 
GPMVs for both expansion and differentiation medium. All the assays performed proves 
the hypothesis that the GPMVs derived from the osteoblast can successfully fuse with the 
hMSCs and induce the osteogenic lineage of the hMSCs.  
 
6.1 Future scope of the work 
 
The pathway by which the GPMVs induces the osteogenic differentiation is still unknown. 
The study should be done find the factors by which the osteogenic lineage is induced in 
MSCs. 
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